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Abstract: An optical approach allowing the extraction and the separation of 
remote vibration sources has recently been proposed. The approach has also 
been applied for medical related applications as blood pressure and heart 
beats monitoring. In this paper we demonstrate its capability to monitor 
glucose concentration in blood stream. The technique is based on the 
tracking of temporal changes of reflected secondary speckle produced in 
human skin (wrist) when being illuminated by a laser beam. A temporal 
change in skin’s vibration profile generated due to blood pulsation is 
analyzed for estimating the glucose concentration. Experimental tests that 
were carried out in order to verify the proposed approach showed good 
match with the change of the glucose level at the positive slope stage as it 
was obtained from conventional reference measurement. 
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1. Introduction 
Diabetes Mellitus, also known as diabetes is a disease in which one's blood sugar level is high. 
Today, diabetes is diagnosed by measuring blood sugar level. In addition, diabetics need to be 
with close supervision on their level of glucose and measure it several times a day [1]. The 
most accurate method is taking blood samples in clinics and hospitals and giving it for 
laboratory analysis, however it is inconvenient to the patients. Diabetes can measure their 
blood glucose level in a less accurate but faster procedure by using a small device that 
diagnoses blood glucose level by analyzing a small sample of their blood. The downside of 
this method is that one still needs to pierce himself in order to use the device. Today, all the 
blood glucose measurement devices must have accuracy following the standards set by the 
International Organization for Standardization (ISO) [2]. In order to be approved, in 95% of 
the time the accuracy value must be within the error range of 20%. Most of homely used 
devices of today have accuracy of 10%-15%. 
Directly related with glucose level, insulin is a hormone that regulates energy and glucose 
metabolism in the body. It affects the liver, muscles and fat tissues causing them to absorb the 
glucose and store it as a glycogen [3]. The situation of surplus glucose in blood can cause 
severe complications to human body. It is caused by either pancreas's malfunction, producing 
low amount of insulin or because the cells in one's body do not absorb the insulin that the 
pancreas produce. 
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Different sensor devices have been proposed for precisely monitoring glucose level while 
attempting to reduce discomfort produced by the need to extract a small sample volume at low 
painful body parts such as palm, thigh forearm and abdomen [4]. In that sense, non-invasive 
glucose meters [5] represent a major breakthrough as the solution to these problems and 
optical techniques are being in the front of those research efforts [6,7]. The non-invasive 
optical techniques include: near infrared spectroscopy - a technique that allows tissue 
investigation in different depths varying from 1 to 100 millimeters [8,9] or 10 to 50 
micrometers [10] by transmitting infrared wavelengths, Raman spectroscopy - a technique 
that measures scattered light that has been influenced by the oscillation and rotation caused by 
glucose [11], photo-acoustic spectroscopy - a technique that measures an acoustic pressure 
wave, created by rapid heating of the sampled area [12,13], scatter and polarization changes - 
techniques that measure the scattering and the polarization properties changes caused by 
glucose [11,14], femtosecond pulse interferometry - a method for determining the glucose 
concentration by measuring the group refraction index of a glucose solution using a time 
delay of femtosecond order in a time-of-flight method with femtosecond pulse interferometry 
[15,16], optical coherence tomography – a technique based on measurement and analysis of 
the interference pattern between the coherently backscattered light from specific layers of 
tissues and a reference beam [17–20], and different types of fluorescence phenomenon  
[21–23]. 
In this paper we adjust the basic operation principle of a novel special optical 
configuration recently developed [24] to monitor level of glucose based on skin vibrations 
caused by blood flux pulsation. The principle of the proposed special optical setup is to 
observe the movement of secondary speckle pattern that is generated on top of the human skin 
(target) when it is being illuminated by a spot of laser beam. We track the temporal shifts and 
movements of this random pattern reflected from the illuminated skin by performing proper 
correlation operations [25]. The applied tracking allows determining both the magnitude and 
the direction of the subject’s local surface displacement when properly adapting the optics of 
the imager as well as the exact image processing algorithm. 
Human blood vessels vibrate due to variable (from systolic to diastolic) blood pressure. 
Human wrist is an ideal spot for blood vessels observation and vibration analysis, especially 
for heart beats monitoring [25]. Moreover, being in a linear proportion with blood pressure 
change, vessels movement is suitable for related blood pressure measurements, namely for 
pulse pressure measurements (the difference between the systolic and diastolic pressures) 
[26]. 
Extraction of various parameters from the vibration profile of the illuminated human skin 
showed that several parameters that are related to the obtained correlation peak can be in a 
good agreement with the glucose level as it is being estimated by conventional reference 
measurement when considering the change of the glucose level at the positive slope region, 
i.e. in the values of the temporal change of the glucose level which starts from the initial level 
and lasts until the highest level is produced (due to glucose intake by the subject). 
In this paper, in Section 2 we present the theoretical explanation, while the experimental 
results are given in Section 3. Section 4 concludes the paper. 
2. Theoretical explanation 
Speckle or speckle pattern may be produced in spatially coherent light due to self-interference 
within the laser beam [27]. The secondary speckle pattern is a pattern that is produced due to 
roughness of an illuminated surface, while it is constructed on the imaging device plain. The 
proposed setup is very simple and robust and it consists of a laser and camera which is slightly 
defocused. The temporal trajectories of the speckle patterns that are captured by the camera 
are proportional to the temporal signals we wish to extract (a vibration profile of the wrist and 
of its veins). A self-interference pattern is constructed on the CCD plane of the observing 
camera. A temporal change in the pattern is related to a relative spatial shift between two 
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adjacent frames taken by the camera as was shown before by Zalevsky et al. [25,26]. Using 
correlation, we extract the relative shift, which is linearly proportional to the tilt of the skin, 
i.e. the tangent of the angle between the skin surface and the laser projection. Finally, all 
relative movements are cumulatively summarized for extracting the total movement vector. 
The connection between different blood parameters and blood glucose level is explained 
by L. S. Jefferson et al. in Ref. [3]: 
 0
(1 ) ( )
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     (1) 
where Cv(t) is the venous glucose concentration at time t, and F is the blood flow (represents 
the amount of blood, usually in litters per minute). Glucose pulse is denoted by q0, it 
represents the amount of glucose (in mg) in the blood (in Kg) per heartbeat, ε is the fraction of 
the glucose pulse that is extracted from the blood system and is metabolized, therefore it will 
never be recovered at the outlet of the vein. h(t) is the reversible fates of glucose in the organ 
that causes a delay and a distortion in the appearance of glucose pulse in the vein. 
If h(t) = 1, the sum of all q0 is Ca˙F and the sum of all Cv(t) is Cv, where Ca and Cv are the 
arterial and venous glucose concentrations respectively. This assumption follows: 
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C C
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    (2) 
Thus, the glucose concentration in the arteries and veins is straightly connected to the glucose 
pulse q0 and the blood flow F. 
A vibration profile of vessel is a unique one. It is characterized by many individual 
parameters as vessel elasticity, human fat layer, blood viscosity etc. Therefore any change of 
one of these parameters can distort this profile. Changes in glucose level in blood affect also 
the viscosity of blood [28], while a change in viscosity of fluid affects the friction between the 
blood fluid and the vessel walls. Our assumption for capability to monitor the glucose level is 
based on the fact that a change of friction due to a change in glucose concentration in the 
arteries and veins causes a distortion of the vibration profile of the vessel. 
The developed optical setup for glucose level estimation is capable to measure the tilt of 
wrist’s skin in respect to the projected laser beam. Our aim is to analyze the change in the 
pulse profile (temporal tilting) by observing quantitative parameters before and after glucose 
intake and to compare it to the actual glucose level in the blood that is obtained as a reference 
measurement with conventional techniques. 
The relative displacement of the skin due to the change in the shape of the vibrating 
surface is proportional to the relative shift of the speckle pattern [25,26]: 
 
4 tan 4        (3) 
where β is proportional to the relative shift of speckle pattern due to skin displacement, α is 
the tilting angle of the skin and λ is the optical wavelength. Assuming that the change in the 
angle is small enough, we obtain a linear proportion between the relative shift and the angle of 
tilting. 
In this paper we show that the temporal change of glucose concentration Cv(t) is 
proportional to the temporal change of β(t) (which is proportional to the relative shift of the 
speckle pattern): 
 ( ) ( )VC t t   (4) 
Therefore, β(t) can be used as possible estimator for glucose concentration in blood. 
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3. Experimental results 
The constructed system is presented in Fig. 1, where one may see a schematic sketch of the 
system (Fig. 1(a)) as well as an image of the camera with its optics and a laser illuminating a 
hand of a subject being fixed by gypsum to allow more accurate measurement (Fig. 1(b)). The 
setup is very simple and includes only a green laser (at 532nm) to illuminate the inspected 
object and a camera (having slightly defocused optics) that is connected to a computer. The 
camera captures images of the secondary speckle pattern being reflected from the hand of the 
subject at rate of 350 frames per second (fps). The focal length of the optics that had been 
used in our experiments was 50mm and the distance from the laser to the subject’s hand was 
about 50cm. The laser output power was about 10mW. 
Hand 
Camera Laser
50 cm
  
        (a).                (b).  
Fig. 1. The implemented optical configuration for remote measuring of glucose level in blood 
from subject’s hand: (a). Sketch of the optical system (b). Subject’s hand under laser 
illumination as viewed by the camera. 
After extracting the speckle pattern in each frame we perform correlation and obtain the 
change in the 2-D position of the peak versus time. In Fig. 2 we show a typical system output 
with high signal to noise ratio. It includes only several pulses related to heart beating, while in 
the experiment we take into account the average of six of them. Every pulse is shaped 
similarly to ECG PQRST [29]. It contains a P pulse, QRS complex, and a T pulse. However, 
this is a mechanical vibration profile, rather than an electrical signal (as ECG) and therefore it 
provides us with additional temporal information about vessel’s vibration due to blood flux 
pulsation. 
#137508 - $15.00 USD Received 1 Nov 2010; revised 6 Feb 2011; accepted 6 Mar 2011; published 14 Mar 2011
(C) 2011 OSA 1 April 2011 / Vol. 2,  No. 4 / BIOMEDICAL OPTICS EXPRESS  862
 Fig. 2. Temporal plot of the outcome from the system used in the clinical tests with the 
graphical description of the observed parameters. 
In this research, we have chosen to monitor two types of parameters: the first is 
proportional to the amplitude change and the second to the temporal change of the relative 
speckle shift. The parameters of the extracted pulse profile that are proportional to amplitude 
change are: main peak amplitude (positive and negative), pulse profile energy (positive and 
negative separately), positive to negative pulse peak ratio, secondary peak amplitude and main 
to secondary peak amplitude ratio. The parameters of the extracted pulse profile that are 
proportional to the temporal change are: pulse width (positive and negative), mean distance 
between peaks (gap or pulse rate), distance from positive to negative peak. These parameters 
are listed in Table 1, while the graphical meaning of them is presented in Fig. 2. 
Table 1. Summary of the Observed Parameters 
N Parameter Units Comments 
    
1 Positive pulse amplitude Pixels Refers to highest amplitude during one heart beat 
2 Positive pulse width Seconds Estimated between 2 zero-crossing points 
3 Positive pulse energy (Pixels)2 Integral of the enclosed area in the positive pulse profile 
4 Gap Seconds Number of frames between 2 peaks (pulse rate) 
5 Negative pulse amplitude Pixels Refers to lowest negative amplitude during one heart beat 
6 Negative pulse width Seconds Estimated between 2 zero-crossing points 
7 Negative pulse energy (Pixels)2 Integral of the enclosed area in the negative pulse profile 
8 Negative gap Seconds Number of frames between 2 negative peaks 
9 Amplitude ratio - Absolute value of the ratio between the positive and the 
negative peaks 
10 Peaks distance Seconds Number of frames between the positive and the negative 
peaks. 
11 Secondary peak amplitude Pixels Refers to S point of QRS- complex 
12 Main to secondary peak 
ratio 
- Absolute ratio between the main and the secondary peaks 
amplitude. 
Amplitude ratio based parameters (parameters #9 and #12) were chosen in order to perform 
the experiment with reduced sensitivity to vibrations of the optical setup itself. Those 
parameters are dimensionless quantities and therefore they are not sensitive to a change in the 
laser’s projection angle. 
In order to make the measurements reliable, we needed to be sure that the same spot on the 
hand is illuminated and examined at every moment. Therefore, an individual hand template 
was constructed using gypsum, while a hole was drilled into it for each one of the subjects to 
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allow the illumination of the wrist (Fig. 1(b)). The diameter of the hole is slightly larger than 
the laser beam's diameter (approximately 1cm). We have tested four healthy subjects from 22 
to 35 years old with different gender and weight. The summary of the subjects’ personal 
information is listed in Table 2. All measurements were repeated several times to assure 
repeatability and correctness. 
Table 2. Summary of the Subjects’ Personal Information 
# Gender Age Weight 
1 Female 22 55 
2 Male 22 62 
3 Female 24 44 
4 Male 35 90 
3.1 Calibration tests 
In order to authenticate the required accuracy of 10-15% variation (as per standard 
glucometer) for reliable experiment results, we needed to be able to illuminate the same spot 
on the wrist over time. We built individual fixation devices for subject’s hand using gypsum 
and executed several check tests. We inserted the hand of the subject, then marked the pulse's 
spot on the hand, drilled a hole through the gypsum in the position of the chosen spot, pulled 
the hand out and re-inserted it. The marked spot was at the exact position. 
Another test was aimed to check the stability of the gypsum fixation over time. Each 
subject inserted his hand into the device and stayed fixed for approximately 30 minutes, while 
he was monitored by the system. In Fig. 3 one can see the stability of the system, while the 
results do not vary more than 15%. Glucose concentration is shown in units of [ml/dl] divided 
by 10 (representing a constant level of 100 [ml/dl]), while the units of parameter #6 (please 
refer to Table 1) are counted in samples. 
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Fig. 3. Stability of the system: constant glucose level in blood (denoted by blue line with 
triangles) and the estimated parameter 6 (denoted by magenta line with rectangles). Glucose 
level is given in units of 0.1[ml/dl] (representing a constant level of 100 [ml/dl), while the 
estimated optical values are given in pixels. 
3.2 Main test 
To ensure that the glucose blood level would rise only as consequence of drinking of a 
sweetened beverage during the experiment, each examined subject preserved a fast for about 
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12 hours before the measurement took place. The expected values of blood glucose level for 
non-diabetic person [1] after fasting falls to values range between 90 to 110 [mg/dl]. At the 
beginning of every experiment we indeed checked that the subject's blood glucose level was at 
this range, while later the subject received a sweetened drink and the level was changed. 
The rate at which the concentration of glucose increases is different for each individual 
and depends on many personal parameters, like: body weight, metabolic rate, level of insulin 
in blood etc. The blood glucose level as we obtained after drinking of about 400ml of 
sweetened beverage (40K Cal) by the subjects was from 150 to190 [mg/dL]. Each experiment 
lasted for 50-80 minutes, during it the measurements were carried out repeatedly every 5 
minutes. Each 5 minutes sampling included capturing six subsequent video files of the 
illuminated spot and taking an accurate blood sample with a glucometer (“Accu-check”) and 
manual blood pressure measurement using standard sphygmomanometer. All experiments 
showed that blood pressure have not been changed over the time of the experiment. It is 
important to check this point in order to ensure that the expected change in the pulse profile is 
indeed caused by glucose intake, rather than by blood pressure change as was shown 
previously in Ref. [26]. 
We wrote a MATLAB program that analyzed the videos and extract the observed 
parameters from the files. Each file contained about 5 seconds of video samples at rate of 350 
fps (frames per second), usually containing 6 pulse peaks. Each peak is processed separately 
and the chosen parameters are extracted and averaged, therefore representing the average of 
approximately 30 peaks of pulse profile per each 5 minutes. For each parameter the final 
graph of the estimated glucose level was produced. Joint graphs of the estimated and the 
reference glucose level for each one of the parameters and for each one of the subjects were 
created. 
Usually we took into an account only the first samples of the estimated values; the ones 
when the glucose level is still rising (the positive slope of the graph). Those samples were 
more reliable due to two main reasons: First is that glucose metabolism mediates changes in 
biochemistry levels: insulinotropic second messengers, including cyclic nucleotides, inositol 
phosphates, diacylglycerol and Ca2+ [30]. Moreover, biochemistry metabolism in limb is not 
linear [3], therefore the change in blood fluid viscosity due to biochemistry metabolism is not 
linear as well. We believe that those metabolic processes initiated by glucose intake in the 
body cause accumulative change in blood viscosity. With some delay after the initial glucose 
intake, the additional metabolic processes affect the change in pulse profile which is not 
directly connected to the actual glucose level change. The second reason is an “exhaustion” of 
the subject. Although gypsum makes reliable fixation, it is not attached “strongly” enough to 
the hand and after approximately half an hour of the experiment the subject can produce 
spontaneous movement which may cause a change in the vibration profile which is not 
connected to the actual glucose change. 
In addition to correlation coefficient, we used root mean square error (RMSE) estimation 
to quantify the relation between the reference and the estimated data: 
 
2
1
( )N i i
i
x rRMSE
N
    (5) 
where xi is an i-th sample of the estimated values, ri is an i-th sample of the reference values 
and N is the number of samples. The calculated samples were normalized before applying 
RMSE estimator in order to obtain the common estimation scale for all parameters. 
Dozens of experiments were executed with four subjects in order to present a proof of 
principle validation. Initial results show a good correspondence of the estimated parameters 
with the positive slop of glucose level change in blood. However the extensive 
characterization of the parameters is in progress. There was not found any good correlation 
between the parameters related to temporal change of the pulse profile and the actual change 
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in the glucose level. However, some of the amplitude related parameters showed a quite good 
matching with the actual glucose change. Some of the obtained results are presented in the 
following figures. 
 
Fig. 4. Data of subject #1: Glucose level in blood and amplitude of positive peak (parameter 
#1). Glucose level is denoted by blue line with triangles and the optically measured parameter 
is denoted by magenta line with rectangles. 
In Figs. 4–8 we present the temporal evolution of the chosen parameters versus the 
reference measurement of glucose level taken by glucometer while glucose concentration in 
blood is denoted by blue line with triangles and the optically measured parameters from the 
pulse profile is denoted by magenta line with squares. The graph of the reference (glucose 
level) was obtained by using a conventional glucose meter device (“Accu-check”). Error bars 
refer to standard deviation of positive and negative deviations separately, calculated over each 
30 peak samples (per each point on the graph). Four different graphs on each figure refer to 
four different experiments taken with relevant subject on different days, during the morning 
hours while each subject preserved a fast of 12 hours. Estimated values were linearly 
transformed to glucose level units according to the calibration done per each subject at the 
first measurement (time 0). Correlation and RMSE coefficients are shown below each graph. 
Figure 4 refers to subject #1, while the best correlative parameters for this subject were 
parameter #1 (please refer to Table 1). 
In Fig. 5 one can see graphs taken with subject #1 which show glucose concentration in 
blood (denoted by blue line with triangles) and the optically measured parameter of the ratio 
between positive and negative peak (parameter #9) of pulse profile (denoted by magenta line 
with squares). Figure 5 shows an exact inverse ratio between the estimated and the reference 
glucose level. Note that parameter #9 is actually a ratio between parameter #1 and #5, 
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therefore it is not sensitive to the vibrations of the optical system. Some of the results showed 
very high correlation with the reference measurement for the full cycle of glucose changes in 
blood. In Fig. 5(b) one can see that the estimated parameter is tracking after the reference 
glucose level (in opposite direction). It comprises the positive and the negative slopes, 
therefore presenting a full cycle of increase and decrease of glucose level in the blood. 
The correlation coefficient of 0.916 was obtained between the two curves. RMSE 
estimator for this parameter was calculated between the inverse function of the normalized 
estimated parameter (one minus the normalized values) and the reference. RMSE estimator is 
equal to 0.17 in this case. However, this estimator was working well only for one subject out 
of four. 
 
Fig. 5. Data of subject #1: Glucose level in blood and the ratio between positive and negative 
peak (parameter #9). Glucose level is denoted by blue line with triangles and the optically 
measured parameter is denoted by magenta line with rectangles. 
Figure 6 refers to subject #2, while the best correlative parameter for this subject was 
found to be positive pulse amplitude (parameter #1). Figure 7 refers to subject #3, while the 
best correlative parameter for this subject was found to be parameter #1 as well. Figure 8 
refers to subject #4, with the best correlative parameter #1. 
Table 3 summaries all correlation coefficients, while Table 4 summaries all RMSE 
estimator coefficients from the graphs presented in Figs. 4–8. 
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 Fig. 6. Data of subject #2: Glucose level in blood and amplitude of positive peak (parameter 
#1). Glucose level is denoted by blue line with triangles and the optically measured parameter 
is denoted by magenta line with rectangles. 
Table 3. Summary of Correlation Coefficients from All the Tests Taken with the Four 
Subjects 
 Parameter Test 1 Test 2 Test 3 Test 4 Average 
Subject #1 Param. #1 0.862 0.945 0.91 0.964 0.92 
Param. #9 0.9 0.916 0.88 0.94 0.909 
Subject #2 Param. #1 0.984 0.896 0.966 0.99 0.959 
Subject #3 Param. #1 0.99 0.93 0.85 0.943 0.928 
Subject #4 Param. #1 0.99 0.88 0.98 0.967 0.954 
Table 4. Summary of RMSE Estimator Coefficients from All the Tests Taken with the 
Four Subjects 
 Parameter Test 1 Test 2 Test 3 Test 4 Average 
Subject #1 Param. #1 0.205 0.17 0.19 0.12 0.171 
Param. #9 0.236 0.17 0.202 0.16 0.192 
Subject #2 Param. #1 0.083 0.21 0.18 0.08 0.138 
Subject #3 Param. #1 0.058 0.18 0.28 0.158 0.169 
Subject #4 Param. #1 0.02 0.21 0.08 0.108 0.105 
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 Fig. 7. Data of subject #3: Glucose level in blood and amplitude of positive peak. Glucose level 
is denoted by blue line with triangles and the optically measured parameter is denoted by 
magenta line with rectangles. 
 
Fig. 8. Data of subject #4: Glucose level in blood and amplitude of positive peak (parameter 
#1). Glucose level is denoted by blue line with triangles and the optically measured parameter 
is denoted by magenta line with rectangles. 
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4. Conclusions 
In this paper we have presented the usage of optical remote configuration for the estimation of 
glucose concentration in blood. The system was tested with clinical trial group while the 
estimated results show a high correlation and low error comparing to reference measurement 
obtained by conventional invasive means. 
We were able to demonstrate that a temporal change in the vibration profile of the pulse 
wave measured from the wrist by our optical technique is proportional to the change of 
glucose concentration in blood when considering the positive slope, i.e. the positive change in 
glucose level. Initial results that were collected from dozens of experiments present validation 
for the proof of principle. However, the extensive characterization of the parameters is in 
progress. 
This new technique means a non-invasive manner of remote measurement of glucose 
concentration in blood, while it uses only a low power emitting laser and a camera. Further 
developments of currently presented technology will allow implementation of autonomic and 
real-time monitoring device, which will be capable of analyzing changes in glucose 
concentration in blood while allowing free movement of the subject. 
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